That is very important, because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (artificial intelligence). But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're created to do. This was a development almost nobody saw. But it's going to have extensive ramifications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (toxic tech 5 tech darlings). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly considerably before going higher - tech stocks. I've been covering bitcoin for a long time now. Among the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. But that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown stock market prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous fantastic private companies on the edge of striking the general public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our normal beat (jeff brown stock market prediction). And when it comes to tech investing, we leave it to the professionals. Luckily, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we understand (jeff brown biotech stock pick for 2020). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid development and developing extraordinary chances for financiers. I want to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. self-driving cars. But regardless of what many readers may think, this is a trend that's just getting begun. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (the legacy report predictions). Losing two months of production and sales actually affects how lots of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is impressive. More importantly, the hold-ups brought on by the pandemic developed a heap of pent-up need. And that need is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown top stock pick 2021. Which's not my only 5G forecast When I've talked about 5G in the past, I have actually described its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services start to be offered (tech stock). That's when we begin to see applications working on 5G networks. Believe of things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: A lot of individuals don't truly appreciate the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities going forward will be huge. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For many years, CRISPR was mostly a niche technology that wasn't well comprehended. And during that time, there were actually just 3 business operating in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This entire market is effectively a greenfield chance.
There's space for many business to exist in this space. jeff brown top biotech stock 2021. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is necessary since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug treatments produced utilizing this technology. This was among those breakthroughs that practically no one discovered. But it's going to have profound ramifications for curing disease. And, obviously, there will be lots of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe significantly prior to going higher. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin - jeff brown genetic sequencing stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. first lady. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date as of February 2021, however we could not separately validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding viewpoint on the market. He's always on the hunt for new opportunities, and he shares much of his finest choices in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully anticipated a few of the most significant financial occasions of the previous twenty years. Although he does not appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it best each time, however Jeff Brown's precise forecasts have actually made him legions of devoted fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research offers numerous research study services with a wide array of specializations - white house.
The business is also connected with Bonner & Partners, another well-respected research publisher - black sea. On its website, Brownstone says its mission is to provide retail financiers with professional-grade research: "For too long, the best financial investment research study has actually not been readily available to individual investors. It has been usually scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. artificial intelligence. The objective of Brownstone Research is to make that type of proprietary research study available to any financiers looking to acquire an edge in the markets. The goal is basic to provide unique and profitable financial investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise works as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown biotech genome sequencing. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown thinks S.A.V. toxic tech 5 tech darlings. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: expert system and electric automobiles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile industry's Holy Grail. As you understand, electric vehicles and self-driving car stocks have been substantial this year, but the Wall Street device has actually approved hype without much concrete result. Despite an extreme increase in competitors over the past couple of years, Brown still thinks Musk has the very best possibility of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Car, and it could be the future of transport. Basically, this innovation would allow you to lease your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the revenues. It sounds ridiculous, but it might be closed than you believe.